D. Salvatore et al., TYPE-2 IODOTHYRONINE DEIODINASE IS HIGHLY EXPRESSED IN HUMAN THYROID, The Journal of clinical investigation, 98(4), 1996, pp. 962-968
Type 2 iodothyronine deiodinase (D2) is a recently cloned selenodeiodi
nase thought to provide intracellular 3,5,3' triiodothyronine (T3) to
a restricted group of tissues, We report here the presence of D2 mRNA
in human thyroid at levels 50-150-fold higher than in placenta, Surpri
singly, while type 1 deiodinase (D1) is known to be present in human t
hyroid, D2 has not been evaluated previously. D2 mRNA was especially h
igh in thyroids from Graves' patients and in follicular adenomas, Stim
ulated thyroids had higher D2 to D1 mRNA ratios than normal or multino
dular glands suggesting differential regulation of D1 and D2 expressio
n, Microsomes from normal, Graves', and TSH-stimulated thyroids contai
ned low K-m D2 activity resistant to propylthiouracil (1 mM) or to ina
ctivation by N-bromoacetyl T3, agents which block or inactivate D1, At
2 nM thyroxine (T4), 100 times the physiological-free T4 levels, 60-8
0% of T4 to T3 conversion in stimulated, but only 27% of that in norma
l thyroids, is catalyzed by D2, We conclude that intrathyroidal T4 to
T3 conversion by D2 may contribute significantly to the relative incre
ase in thyroidal T3 production in patients with Graves' disease, toxic
adenomas, and, perhaps, iodine deficiency.